Glenmark Pharmaceuticals gets final approval for Indomethacin Extended-Release Capsules
From USFDA
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Indomethacin Extended-Release Capsules USP, 75 mg, the generic version of Indocin SR Extended-Release Capsules, 75 mg of Iroko Pharmaceuticals LLC.According to IMS Health sales data for the 12 month period ending April 2017, the Indocin SR Extended-Release Capsules, 75 mg market1 achieved annual sales of approximately $6.3 million*.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 27 2017 | 8:59 AM IST